Approaching the asymptote
- PMID: 36354048
- DOI: 10.1016/S2352-3018(22)00310-1
Approaching the asymptote
Conflict of interest statement
DK has received consulting fees from AbbVie, Gilead, GlaxoSmithKline, Janssen, Merck, Roche, and ViiV for participation on Advisory Boards; honoraria for lectures from Gilead and Janssen; and payment for expert testimony from Gilead. DK has also received payment from GlaxoSmithKline and ViiV for participation on Data Safety and Monitoring Boards.
Comment on
-
Immunological and virological findings in a patient with exceptional post-treatment control: a case report.Lancet HIV. 2023 Jan;10(1):e42-e51. doi: 10.1016/S2352-3018(22)00302-2. Epub 2022 Oct 27. Lancet HIV. 2023. PMID: 36354046
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical